AMPE
Ampio Pharmaceuticals, Inc.·Healthcare
0.15
0.000%(+0.00)
Market ClosedLast Updated: — ET
52W L: $0.0052W H: $0.29
AMPE NEWS
defenseworld.net
Jan 28
Head to Head Comparison: Ampio Pharmaceuticals (NYSE:AMPE) & Vincerx Pharma (NASDAQ:VINC)
Institutional and Insider Ownership 44.0% of Vincerx Pharma shares are held by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 15.6% of Vincerx Pharma shares are held by insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments
defenseworld.net
Jan 15
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN)
Profitability This table compares Trevena and Ampio Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Trevena N/A N/A -119.55% Ampio Pharmaceuticals N/A N/A N/A Earnings and Valuation This table compares Trevena and Ampio Pharmaceuticals"s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio
defenseworld.net
Jan 11
Ampio Pharmaceuticals (NYSE:AMPE) and Graybug Vision (NASDAQ:GRAY) Financial Contrast
Volatility and Risk Graybug Vision has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 5.57, indicating that its share price is 457% more volatile than the S&P 500. Valuation and Earnings This table compares Graybug Vision and Ampio Pharmaceuticals"s
